Omega Common Stock Total Equity vs Other Assets Analysis
OHI Stock | USD 30.63 0.05 0.16% |
Omega Healthcare financial indicator trend analysis is much more than just breaking down Omega Healthcare Inv prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omega Healthcare Inv is a good investment. Please check the relationship between Omega Healthcare Common Stock Total Equity and its Other Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Common Stock Total Equity vs Other Assets
Common Stock Total Equity vs Other Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omega Healthcare Inv Common Stock Total Equity account and Other Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Omega Healthcare's Common Stock Total Equity and Other Assets is 0.6. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Other Assets in the same time period over historical financial statements of Omega Healthcare Investors, assuming nothing else is changed. The correlation between historical values of Omega Healthcare's Common Stock Total Equity and Other Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of Omega Healthcare Investors are associated (or correlated) with its Other Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Assets has no effect on the direction of Common Stock Total Equity i.e., Omega Healthcare's Common Stock Total Equity and Other Assets go up and down completely randomly.
Correlation Coefficient | 0.6 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.Other Assets
Most indicators from Omega Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omega Healthcare Inv current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. As of now, Omega Healthcare's Selling General Administrative is increasing as compared to previous years. The Omega Healthcare's current Tax Provision is estimated to increase to about 3.4 M, while Issuance Of Capital Stock is projected to decrease to under 228.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.0B | 861.3M | 934.7M | 981.5M | Total Revenue | 1.1B | 878.2M | 949.7M | 997.2M |
Omega Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Omega Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Omega Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.8B | 9.5B | 9.6B | 9.4B | 9.1B | 9.6B | |
Short Long Term Debt Total | 5.1B | 5.2B | 5.3B | 5.3B | 5.1B | 5.3B | |
Other Current Liab | 312.0M | 280.8M | 268.4M | 315.0M | 287.8M | 302.2M | |
Total Current Liabilities | 437.0M | 382.0M | 268.5M | 334.3M | 308.2M | 234.0M | |
Total Stockholder Equity | 4.1B | 3.8B | 3.9B | 3.6B | 3.6B | 3.8B | |
Property Plant And Equipment Net | (11.4M) | (10.8M) | (8.2M) | 17.8M | 30.2M | 28.7M | |
Net Debt | 5.1B | 5.0B | 5.2B | 5.0B | 4.6B | 4.9B | |
Retained Earnings | (1.8B) | (2.3B) | (2.5B) | (2.7B) | (3.2B) | (3.0B) | |
Non Current Assets Total | 8.6B | 8.1B | 8.2B | 7.6B | 6.9B | 7.2B | |
Non Currrent Assets Other | 7.3B | 6.8B | 6.9B | 6.8B | 6.0B | 6.3B | |
Other Assets | 830.5M | 7.8B | 7.4B | 6.9B | 6.0B | 6.3B | |
Net Receivables | 1.2B | 1.1B | 1.1B | 1.5B | 1.7B | 1.8B | |
Common Stock Shares Outstanding | 222.1M | 235.1M | 244.3M | 244.3M | 250.5M | 263.0M | |
Liabilities And Stockholders Equity | 9.8B | 9.5B | 9.6B | 9.4B | 9.1B | 9.6B | |
Non Current Liabilities Total | 5.0B | 5.1B | 5.3B | 5.3B | 5.0B | 5.3B | |
Other Stockholder Equity | 6.0B | 6.2B | 6.4B | 6.3B | 3.5B | 2.3B | |
Total Liab | 5.5B | 5.5B | 5.5B | 5.6B | 5.4B | 5.6B | |
Total Current Assets | 1.2B | 1.4B | 1.4B | 1.8B | 2.3B | 2.4B | |
Short Term Debt | 125M | 101.2M | 96K | 19.2M | 20.4M | 19.4M | |
Intangible Assets | 28.0M | 1.9M | 1.6M | 1.4M | 682K | 647.9K | |
Common Stock | 22.7M | 23.1M | 23.9M | 23.4M | 24.5M | 12.3M | |
Accumulated Other Comprehensive Income | (39.9M) | (12.8M) | (2.2M) | 20.3M | 29.3M | 30.8M | |
Other Liab | 71.5M | 10.8M | 8.2M | 21.8M | 25.1M | 23.9M | |
Cash | 24.1M | 163.5M | 20.5M | 297.1M | 442.8M | 465.0M | |
Long Term Debt | 389.7M | 369.5M | 5.3B | 5.3B | 5.0B | 5.3B | |
Cash And Short Term Investments | 24.1M | 163.5M | 20.5M | 297.1M | 442.8M | 465.0M | |
Property Plant Equipment | 7.2B | 6.7B | 6.8B | 6.5B | 7.5B | 7.9B | |
Common Stock Total Equity | 22.7M | 23.1M | 23.9M | 23.4M | 26.9M | 14.5M | |
Other Current Assets | (441.6M) | (412.6M) | (287.5M) | (486.7M) | (671.3M) | (637.7M) | |
Net Tangible Assets | 3.5B | 3.2B | 3.3B | 3.0B | 3.4B | 2.6B | |
Noncontrolling Interest In Consolidated Entity | 201.2M | 194.7M | 201.4M | 193.9M | 223.0M | 182.8M | |
Accounts Payable | 5.1B | 280.8M | 268.5M | 315.0M | 362.3M | 664.3M | |
Good Will | 644.4M | 651.7M | 651.4M | 643.2M | 643.9M | 456.7M | |
Retained Earnings Total Equity | (1.8B) | (2.3B) | (2.5B) | (2.7B) | (2.5B) | (2.4B) | |
Long Term Debt Total | 389.7M | 369.5M | 5.3B | 5.3B | 6.1B | 6.4B | |
Capital Surpluse | 6.0B | 6.2B | 6.4B | 6.3B | 7.3B | 4.5B |
Currently Active Assets on Macroaxis
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Omega Healthcare Inv information on this page should be used as a complementary analysis to other Omega Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Omega Stock analysis
When running Omega Healthcare's price analysis, check to measure Omega Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Healthcare is operating at the current time. Most of Omega Healthcare's value examination focuses on studying past and present price action to predict the probability of Omega Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Healthcare's price. Additionally, you may evaluate how the addition of Omega Healthcare to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Omega Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.773 | Dividend Share 2.68 | Earnings Share 1.12 | Revenue Per Share 4.007 | Quarterly Revenue Growth 0.115 |
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.